XASX
GLH
Market cap2mUSD
Jul 07, Last price
0.07AUD
1Q
-2.99%
Jan 2017
-84.95%
IPO
-99.19%
Name
Global Health Ltd
Chart & Performance
P/E
—
P/S
0.44
EPS
—
Div Yield, %
—
Shrs. gr., 5y
8.32%
Rev. gr., 5y
7.74%
Revenues
9m
+6.68%
Net income
-867k
L-33.95%
CFO
-707k
L-37.62%
Dividend
Feb 28, 20170.01 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Melbourne, Australia, and established in 1985, Global Health Limited develops and supplies digital health solutions for the Australian healthcare sector. Their comprehensive suite of software addresses various needs, including specialized platforms for mental health practitioners like psychologists and psychiatrists. The company provides integrated solutions across community health and human services, encompassing areas such as drug and alcohol support, disability services, post-acute and community care, and rehabilitation. Furthermore, they offer solutions for home and aged care, general practice, pharmacies, and consumer engagement. Key products include the MasterCare Electronic Medical Record (EMR), MasterCare + for digitizing services, and MasterCare Patient Administration System (PAS). PrimaryClinic provides medical and practice management capabilities for GPs and specialists, enabling shared patient demographic data. Other significant tools are ReferralNet for secure document exchange, LifeCard as a personal health record, and HotHealth for digital patient engagement. Complementing these are the MasterCare Data Warehouse for streamlined data analysis, e-switch middleware for seamless system integration, a Patient Portal for digital pre-admission data capture, and Altitude, their cloud hosting service.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||